Citadel Advisors - XTL BIOPHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of XTL BIOPHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2016$50,000
-25.4%
83,175
+17.8%
0.00%
Q3 2016$67,000
+294.1%
70,591
+345.1%
0.00%
Q1 2016$17,00015,8580.00%
Other shareholders

There were no reported owners of XTL BIOPHARMACEUTICALS LTD in Q1 2017.

NameSharesValueWeighting ↓
View complete list of XTL BIOPHARMACEUTICALS LTD shareholders